Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo.

MLA

Zheng, Xiaohong, et al. “Antitumour Effects of Tetrazanbigen against Human Hepatocellular Carcinoma QGY-7701 through Inducing Lipid Accumulation in Vitro and in Vivo.” The Journal of Pharmacy and Pharmacology, vol. 67, no. 11, Nov. 2015, pp. 1593–602. EBSCOhost, https://doi.org/10.1111/jphp.12467.

APA

Zheng, X., Li, W., Lan, Z., Yang, X., Li, L., Yuan, Y., Xia, Z., Chen, X., Zhang, X., & Yu, Y. (2015). Antitumour effects of tetrazanbigen against human hepatocellular carcinoma QGY-7701 through inducing lipid accumulation in vitro and in vivo. The Journal of Pharmacy and Pharmacology, 67(11), 1593–1602. https://doi.org/10.1111/jphp.12467

Chicago

Zheng, Xiaohong, Wei Li, Zuoping Lan, Xiaolan Yang, Longjiang Li, Yonghua Yuan, Zhu Xia, Xunguan Chen, Xinyu Zhang, and Yu Yu. 2015. “Antitumour Effects of Tetrazanbigen against Human Hepatocellular Carcinoma QGY-7701 through Inducing Lipid Accumulation in Vitro and in Vivo.” The Journal of Pharmacy and Pharmacology 67 (11): 1593–1602. doi:10.1111/jphp.12467.